16:35 EDT Acelyrin Inc trading resumes
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on SLRN:
- Acelyrin (NASDAQ: SLRN) Plummets on Disappointing HS Trial Results
- ACELYRIN, INC. Announces Top-Line Results from Placebo-Controlled Clinical Trial of Izokibep for Moderate-to-Severe Hidradenitis Suppurativa
- ACELYRIN, INC. to Present at the Morgan Stanley 21st Annual Global Healthcare Conference
- Acelyrin price target raised to $39 from $29 at Morgan Stanley
- Acelyrin initiated with a Buy at H.C. Wainwright